Head-to-head · free

SURG vs Tessera Technologies

SURG vs TSRA — return on capital, cash generation, margins and balance sheet side by side.

SURG

0 / 0

measures where SURG leads

TSRA

0 / 0

measures where TSRA leads

A simple count of which company scores better on each measure — not a recommendation to buy or sell.

MeasureSURG · FY2025TSRA
Revenue$57.0M—
Net income(36.1M)—
Revenue growth (yearly, multi-year)2.8%—
Free cash flow(21.3M)—
Free cash flow margin-37.4%—
Net cash / (debt)——
ROIC——
Return on equity——
Gross margin-18.6%—
Operating margin-53.8%—
Net debt / EBITDA-0.35x—

Figures are as reported by each company; latest fiscal year shown.

Where SURG's cash went (FY2025)

Capital spending
$18590
Buybacks
—
Dividends
—
Acquisitions
—
Net debt issued / (repaid)
—
Full SURG profile →

Where Tessera Technologies's cash went

Not reported yet.

Full TSRA profile →

Ask which business is stronger

"Which one reinvests at higher returns?" "Who carries more risk in its filings?" Get answers drawn straight from both companies' filings.

Compare them free

More comparisons